Fed. Circ. Upholds Edwards' PTAB Win On Heart Valve Patent

By Adam Lidgett · March 21, 2024, 5:53 PM EDT

The Federal Circuit has affirmed a Patent Trial and Appeal Board finding that various parts of medical technology maker Cardiovalve's patent on an artificial heart valve implant were invalid as obvious....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Cardiovalve Ltd. v. Edwards Lifesciences Corporation

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

-

Date Filed

September 21, 2022

Recent Articles By Adam

April 30, 2024
FTC Continues To Target 'Junk' Drug Patents
April 10, 2024
Pharmacy Gets Eli Lilly's Mounjaro Suit Tossed
April 09, 2024
Endo Sues FDA Over Generic Adrenalin Approvals
March 25, 2024
Vidal Vacates Denials Of Challenges To Neo Wireless IP
March 21, 2024
Business Coalition Rebuffs Biden Plan To Seize Drug Patents
March 06, 2024
J&J Seeks Exit From Suit Over Stelara Exclusivity
March 06, 2024
PTAB Has To Rehear Challenge In Biotech Row
March 05, 2024
Magnolia Medical Again Sues Kurin Over Sepsis IP
February 27, 2024
Judge Trims Medical Device Royalty Fight
February 23, 2024
J&J Unit Assails Knee Replacement IP Verdict At Fed. Circ.